abstract |
Nanobodies specifically binding to human serum albumin (HSA) and applications thereof. The present invention specifically relates to alpaca and humanized nanobodies or antigen binding fragments thereof capable of binding to HSA, having good affinity with human, rat, monkey serum albumin, and having great significance in the treatment of cancer and autoimmune diseases. |